Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma
NCT07727954
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Melasma
Interventions
DRUG:
Topical azelaic acid 12% plus tranexamic acid 5%
DRUG:
Placebo topical formulation
Sponsor
University of Guadalajara